Spots Global Cancer Trial Database for recurrent inflammatory breast carcinoma
Every month we try and update this database with for recurrent inflammatory breast carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Talimogene Laherparepvec in Treating Patients With Recurrent Breast Cancer That Cannot Be Removed by Surgery | NCT02658812 | Malignant Chest... Recurrent Breas... Recurrent Infla... Stage IV Breast... Stage IV Inflam... | Laboratory Biom... Talimogene Lahe... | 18 Years - | M.D. Anderson Cancer Center |